http://www.cuebiopharma.com
Cue Biopharma, Inc. Company Intro
Cue Biopharma, a clinical-stage biopharmaceutical company, is engineering a novel class of injectable biologics to selectively engage and modulate targeted T cells within the body to transform the treatment of cancer and autoimmune diseases. The company’s proprietary platform, Immuno-STAT™ (Selective Targeting and Alteration of T cells), is designed to harness the body’s intrinsic immune system without […]
Industry
Healthcare
Cue Biopharma, Inc. Headquaters
21 Erie Street
Cambridge,02139
United States
Cue Biopharma, Inc. Share price
28 Jan 2021 01:28 GMT
$13.59
-0.41 (-2.93 %)
Cue Biopharma, Inc. Market cap
$393.619 M
WMC RANKING
2021
Cue Biopharma, Inc. # 223
BiotechnologyLatest Cue Biopharma, Inc. News
27 Jan 2021
Is Cue Biopharma, Inc. (NASDAQ:CUE) Popular Amongst ...
Cue Biopharma is a smaller company with a market capitalization of US$424m, so it may still be flying under the radar of many institutional investors. In the chart ...
25 Jan 2021
Street Set To Open Broadly Higher
... Cue Biopharma's Chief Medical Officer, Kenneth Pienta, made a $40,980 buy of CUE, purchasing 2,720 shares at a cost of $15.07 each. Cue Biopharma Inc is ...
25 Jan 2021
What is the Market's View on Cue Biopharma Inc (CUE ...
Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologic drugs for the selective modulation of ...
WMC Market Score
WMC Market to Revenue Score
Cue Biopharma, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| Cue Biopharma, Inc. | USD | $3,458 | $40,228 | $-36,699 | $3,936M | 223 |
| Regeneron Pharmaceuticals, Inc. | USD | $9,243,500 | $5,152,600 | $3,156,000 | $550,130B | 1 |
| Alexion Pharmaceuticals, Inc. | USD | $5,862,400 | $2,588,400 | $956,600 | $340,530B | 2 |
| Vertex Pharmaceuticals Incorporated | USD | $5,991,128 | $2,596,854 | $2,690,691 | $585,740B | 3 |
| ALK-Abello A/S | USD | $3,383,000 | $1,831,000 | $43,000 | $263,140B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total Cue Biopharma, Inc. Social Followers vs Top 4 Industry Competitors
Cue Biopharma, Inc. Post vs Top 4 Industry Competitors
Cue Biopharma, Inc. Digital Footprint By Size vs Top 4 Industry Competitors
Cue Biopharma, Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors
Cue Biopharma, Inc. WMC Market Score Calculations
| Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
| Cue Biopharma, Inc. | 0.04 | 0.34 | 1.36 | 0 | 0 | 0 | 0.90 |
| Regeneron Pharmaceuticals, Inc. | 100 | 66.55 | 10.99 | 100 | 0 | 0 | 93.89 |
| Alexion Pharmaceuticals, Inc. | 63.42 | 16.60 | 100 | 60 | 0 | 0 | 93.45 |
| Vertex Pharmaceuticals Incorporated | 64.81 | 100 | 3.26 | 86 | 0 | 0 | 100 |
| ALK-Abello A/S | 36.60 | 0 | 0 | 0 | 0 | 0 | 0 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
